CLAIM #3180 · Abbott Laboratories (ABT) · 2024Q3 earnings call · Oct 16, 2024 · due Dec 31, 2024
“So I expect to see international pediatric and overall nutrition growth step up in the quarter.”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2024Q3 earnings call.